Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 1998, 63, 103-114
https://doi.org/10.1135/cccc19980103

2,4-Dihydroxyacetophenone Derivatives as Antileukotrienics with a Multiple Activity Mechanism

Miroslav Kuchař, Kateřina Čulíková, Vladimíra Panajotovová, Bohumila Brunová, Antonín Jandera and Vojtěch Kmoníček

Research Institute for Pharmacy and Biochemistry, 130 60 Prague 3, Czech Republic

Crossref Cited-by Linking

  • KUCHAR M., CULIKOVA K., PANAJOTOVOVA V., BRUNOVA B., JANDERA A., KMONICEK V.: ChemInform Abstract: 2,4-Dihydroxyacetophenone Derivatives as Antileukotrienics with a Multiple Activity Mechanism. ChemInform 2010, 29, no. <https://doi.org/10.1002/chin.199819095>
  • Junek Richard, Brůnová Bohumila, Kverka Miloslav, Panajotová Vladimíra, Jandera Antonín, Kuchař Miroslav: Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis. European Journal of Medicinal Chemistry 2007, 42, 1084. <https://doi.org/10.1016/j.ejmech.2007.01.014>
  • Serban D.N., Serban I.L., Nechifor M.: Effects of novel leukotriene receptor antagonists in the isolated rat aorta. Prostaglandins, Leukotrienes and Essential Fatty Acids 2006, 74, 385. <https://doi.org/10.1016/j.plefa.2006.03.009>
  • Kuchař Miroslav, Kmoníček Vojtěch, Panajotová Vladimíra, Jandera Antonín, Brunová Bohumila, Junek Richard, Bucharová Věra, Čejka Jan, Šatinský Dalibor: Derivatives of (Phenylsulfanyl)benzoic Acids with Multiple Antileukotrienic Activity. Collect. Czech. Chem. Commun. 2004, 69, 2098. <https://doi.org/10.1135/cccc20042098>
  • Szotáková Barbora, Skálová Lenka, Baliharová Vendula, Dvorščaková Martina, Štorkánová Lenka, Šišpera Luděk, Wsól Vladimír: Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes. Journal of Pharmacy and Pharmacology 2004, 56, 205. <https://doi.org/10.1211/0022357023060>
  • Jampílek J., Doleẑal M., Kuneŝ J., Víchová P., Jun D., Hanika Jir̂í, O'Connor R., Clynes M.: Synthesis of (2E)-2-methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)prop-2-enoic acid (VUFB 20609) and 2-methyl-3-(4-{[4-(quinolin-2-ylmethoxy)phenyl]sulfanyl}phenyl)propanoic acid (VUFB 20584) as potential antileukotrienic agents. Journal of Pharmacy and Pharmacology 2004, 56, 783. <https://doi.org/10.1211/0022357023484>